6. Nagata Y, Sawada R, Takashima A, Shoji H, Honma Y, Iwasa S, Amano K, Kato K, Hamaguchi T, Shimada Y, Saruta M, Boku N. 2019; Efficacy and safety of pemetrexed plus cisplatin as first-line chemotherapy in advanced malignant peritoneal mesothelioma. Jpn J Clin Oncol. 49:1004–1008. DOI:
10.1093/jjco/hyz104. PMID:
31287877.
Article
7. Fennell DA, Rudd RM. 2004; Defective core-apoptosis signalling in diffuse malignant pleural mesothelioma: opportunities for effective drug development. Lancet Oncol. 5:354–362. DOI:
10.1016/S1470-2045(04)01492-5. PMID:
15172356.
Article
8. Galani V, Varouktsi A, Papadatos SS, Mitselou A, Sainis I, Constantopoulos S, Dalavanga Y. 2019; The role of apoptosis defects in malignant mesothelioma pathogenesis with an impact on prognosis and treatment. Cancer Chemother Pharmacol. 84:241–253. DOI:
10.1007/s00280-019-03878-3. PMID:
31119375.
Article
9. Grootjans S, Vanden Berghe T, Vandenabeele P. 2017; Initiation and execution mechanisms of necroptosis: an overview. Cell Death Differ. 24:1184–1195. DOI:
10.1038/cdd.2017.65. PMID:
28498367. PMCID:
PMC5520172.
Article
12. Salehi B, Venditti A, Sharifi-Rad M, Kręgiel D, Sharifi-Rad J, Durazzo A, Lucarini M, Santini A, Souto EB, Novellino E, Antolak H, Azzini E, Setzer WN, Martins N. 2019; The therapeutic potential of apigenin. Int J Mol Sci. 20:1305. DOI:
10.3390/ijms20061305. PMID:
30875872. PMCID:
PMC6472148.
Article
15. Edmondson R, Broglie JJ, Adcock AF, Yang L. 2014; Three-dimensional cell culture systems and their applications in drug discovery and cell-based biosensors. Assay Drug Dev Technol. 12:207–218. DOI:
10.1089/adt.2014.573. PMID:
24831787. PMCID:
PMC4026212.
Article
16. Nunes AS, Barros AS, Costa EC, Moreira AF, Correia IJ. 2019; 3D tumor spheroids as in vitro models to mimic in vivo human solid tumors resistance to therapeutic drugs. Biotechnol Bioeng. 116:206–226. DOI:
10.1002/bit.26845. PMID:
30367820.
Article
17. Chambers KF, Mosaad EM, Russell PJ, Clements JA, Doran MR. 2014; 3D cultures of prostate cancer cells cultured in a novel high-throughput culture platform are more resistant to chemotherapeutics compared to cells cultured in monolayer. PLoS One. 9:e111029. DOI:
10.1371/journal.pone.0111029. PMID:
25380249. PMCID:
PMC4406579.
Article
18. Federici C, Petrucci F, Caimi S, Cesolini A, Logozzi M, Borghi M, D'Ilio S, Lugini L, Violante N, Azzarito T, Majorani C, Brambilla D, Fais S. 2014; Exosome release and low pH belong to a framework of resistance of human melanoma cells to cisplatin. PLoS One. 9:e88193. DOI:
10.1371/journal.pone.0088193. PMID:
24516610.
Article
20. Masuelli L, Benvenuto M, Mattera R, Di Stefano E, Zago E, Taffera G, Tresoldi I, Giganti MG, Frajese GV, Berardi G, Modesti A, Bei R. 2017; In vitro and in vivo anti-tumoral effects of the flavonoid apigenin in malignant mesothelioma. Front Pharmacol. 8:373. DOI:
10.3389/fphar.2017.00373. PMID:
28674496. PMCID:
PMC5474957.
Article
21. Tait SW, Ichim G, Green DR. 2014; Die another way--non-apoptotic mechanisms of cell death. J Cell Sci. 127(Pt 10):2135–2144. DOI:
10.1242/jcs.093575. PMID:
24833670. PMCID:
PMC4021468.
25. Carlisi D, Buttitta G, Di Fiore R, Scerri C, Drago-Ferrante R, Vento R, Tesoriere G. 2016; Parthenolide and DMAPT exert cytotoxic effects on breast cancer stem-like cells by inducing oxidative stress, mitochondrial dysfunction and necrosis. Cell Death Dis. 7:e2194. DOI:
10.1038/cddis.2016.94. PMID:
27077810. PMCID:
PMC4855673.
Article
26. Chen S, Lv X, Hu B, Zhao L, Li S, Li Z, Qing X, Liu H, Xu J, Shao Z. 2018; Critical contribution of RIPK1 mediated mitochondrial dysfunction and oxidative stress to compression-induced rat nucleus pulposus cells necroptosis and apoptosis. Apoptosis. 23:299–313. DOI:
10.1007/s10495-018-1455-x. PMID:
29705943.
Article
27. Eguchi Y, Shimizu S, Tsujimoto Y. 1997; Intracellular ATP levels determine cell death fate by apoptosis or necrosis. Cancer Res. 57:1835–1840. PMID:
9157970.